Prescription Opioid Misuse and Public Health Approach in Australia

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Substance Use & Misuse

• Publication date

  2018-01-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/10826084.2017.1305415PMID 28605278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reducing the Risks of Relief--The CDC Opioid-Prescribing Guideline.

  2016cited by this paper
• Prescription drug monitoring in Australia: capacity and coverage issues

  2016influential reference
• Pain, alcohol use disorders and risky patterns of drinking among people with chronic non-cancer pain receiving long-term opioid therapy.

  2016cited by this paper
• Use of Opioid Analgesics in Older Australians.

  2015cited by this paper
• The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain

  2015cited by this paper
• A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.

  2015cited by this paper
• An overview of the patterns of prescription opioid use, costs and related harms in Australia.

  2014cited by this paper
• Overview of Substance Use and Treatment from Australia

  2014cited by this paper
• A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence.

  2014cited by this paper
• Pharmaceutical drug misuse in Australia

  2014cited by this paper
• An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions

  2014cited by this paper
• Real‐time monitoring of Schedule 8 medicines in Australia: evaluation is essential

  2013cited by this paper
• The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids

  2013cited by this paper
• Adverse Selection? A Multi-Dimensional Profile of People Dispensed Opioid Analgesics for Persistent Non-Cancer Pain

  2013cited by this paper
• A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner's Guide.

  2012cited by this paper
• Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds

  2012cited by this paper
• Waiting room ambience and provision of opioid substitution therapy in general practice

  2012cited by this paper
• Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings.

  2012cited by this paper
• Change in Quality of Life and Its Predictors in Heroin Users Receiving Methadone Maintenance Treatment in Taiwan: An 18-Month Follow-Up Study

  2012cited by this paper
• Opioids for Chronic Noncancer Pain: As the Pendulum Swings, Who Should Set Prescribing Standards for Primary Care?

  2012cited by this paper
• Opioid epidemic in the United States.

  2012influential reference
• Influence of prescription monitoring programs on analgesic utilization by an insured retiree population

  2012cited by this paper
• Oral naltrexone maintenance treatment for opioid dependence.

  2011cited by this paper
• Opioid substitution therapy--a study of GP participation in prescribing.

  2011cited by this paper
• Oral naltrexone maintenance treatment for opioid dependence.

  2011cited by this paper
• The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment.

  2010cited by this paper
• Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base.

  2010cited by this paper
• Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

  2009cited by this paper
• The Promotion and Marketing of OxyContin : Commercial Triumph , Public Health Tragedy

  2009cited by this paper
• Examination of opioid prescribing in Australia from 1992 to 2007

  2009cited by this paper
• The influence of prescription monitoring programs on chronic pain management.

  2009cited by this paper
• Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention.

  2009cited by this paper
• The promotion and marketing of oxycontin: commercial triumph, public health tragedy.

  2009cited by this paper
• The law of unintended consequences: when pain management leads to medication errors.

  2008cited by this paper
• Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

  2003cited by this paper

• Influences of Software Changes on Oxycodone Prescribing at an Australian Tertiary Emergency Department: A Retrospective Review

  2024cites this paper
• The contribution of pain catastrophizing, depression and anxiety symptoms among patients with persistent pain and opioid misuse behaviours

  2023cites this paper
• The Opioid Epidemic as Collective Trauma: An Introduction to the Crisis

  2022influential citation
• How do patient, pharmacist and medication characteristics and prescription drug monitoring program alerts influence pharmacists' decisions to dispense opioids? A randomised controlled factorial experiment.

  2022cites this paper
• Association of Medication Treatment for Opioid Use Disorder With Suicide Mortality.

  2022cites this paper
• Pharmacists opioid risk and safety counseling practices: A latent class analysis approach.

  2021cites this paper
• How prescription drug monitoring programs influence clinical decision-making: A mixed methods systematic review and meta-analysis.

  2021cites this paper
• Association of sociodemographic factors with the prescription pattern of opioids for dental patients: A systematic review protocol.

  2021cites this paper
• The Pain Nurse Practitioner and Pain Nurse's Role and Views on Opioid Management in Australia: A National Questionnaire Survey.

  2021cites this paper
• Post‐discharge opioid prescribing after laparoscopic appendicectomy and cholecystectomy

  2020cites this paper
• Strengths, challenges, and future directions for the non-government alcohol and other drugs workforce

  2020cites this paper
• Supply of codeine combination analgesics from Australian pharmacies in the context of voluntary real-time recording and regulatory change: A simulated patient study.

  2019cites this paper
• A comparison of opioids and benzodiazepines dispensing in Australia

  2019cites this paper
• What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine

  2019cites this paper
• Pattern and probability of dispensing of prescription opioids and benzodiazepines among the new users in Australia: a retrospective cohort study

  2019cites this paper
• Global use and misuse of opioids

  2018cites this paper
• Opioid misuse in gastroenterology and non-opioid management of abdominal pain

  2018cites this paper
• Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue

  2018influential citation
• The evolving drug epidemic of prescription opioid injection and its association with HCV transmission among people who inject drugs in Montréal, Canada

  2018cites this paper
• Opioid Misuse as a Predictor of Alcohol Treatment Outcomes in the COMBINE Study: Mediation by Medication Adherence

  2018cites this paper
• Principles for managing OUD related to chronic pain in the Nordic countries based on a structured assessment of current practice

  2018influential citation